Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.08
-18.6%
$0.10
$0.08
$0.47
$864K0.458,137 shs403 shs
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
$0.15
+2.5%
$0.21
$0.13
$62.60
$3.83M-0.142.25 million shs5.76 million shs
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
$3.34
+0.3%
$3.16
$2.36
$13.50
$3.61M2.61126,612 shs9,978 shs
Quoin Pharmaceuticals, Ltd. stock logo
QNRX
Quoin Pharmaceuticals
$7.65
+20.3%
$7.72
$5.01
$54.95
$4.50M1.39133,854 shs9.72 million shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dynatronics Co. stock logo
DYNT
Dynatronics
-18.60%+0.37%-32.17%-41.77%-79.90%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
+2.47%-12.00%-12.00%-71.06%-99.73%
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
+0.30%-3.47%-3.19%-12.34%-57.77%
Quoin Pharmaceuticals, Ltd. stock logo
QNRX
Quoin Pharmaceuticals
+20.28%+24.80%+44.89%-33.97%-71.90%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/AN/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.8591 of 5 stars
0.03.00.00.02.61.70.6
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
2.8492 of 5 stars
3.55.00.00.02.00.01.3
Quoin Pharmaceuticals, Ltd. stock logo
QNRX
Quoin Pharmaceuticals
0.3137 of 5 stars
0.03.00.00.01.60.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00
N/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.00
N/AN/AN/A
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
3.00
Buy$13.00289.22% Upside
Quoin Pharmaceuticals, Ltd. stock logo
QNRX
Quoin Pharmaceuticals
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest DYNT, GCTK, HSCS, and QNRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/18/2025
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $14.00
(Data available from 5/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Dynatronics Co. stock logo
DYNT
Dynatronics
$33.60M0.03N/AN/A$0.57 per share0.14
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/A$15.30 per shareN/A
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
$14.70K245.61N/AN/A$11.16 per share0.30
Quoin Pharmaceuticals, Ltd. stock logo
QNRX
Quoin Pharmaceuticals
N/AN/AN/AN/A$5.74 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Dynatronics Co. stock logo
DYNT
Dynatronics
-$2.70M-$0.82N/AN/A-8.35%-41.81%-9.56%N/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
-$7.10M-$56.60N/AN/AN/A-826.43%-707.26%5/21/2025 (Estimated)
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
-$6.61M-$7.48N/AN/AN/AN/A-117.76%-84.09%N/A
Quoin Pharmaceuticals, Ltd. stock logo
QNRX
Quoin Pharmaceuticals
-$8.69M-$81.12N/AN/AN/AN/A-125.60%-64.77%N/A

Latest DYNT, GCTK, HSCS, and QNRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/A-$0.34N/A-$0.67N/AN/A
5/13/2025Q1 2025
Quoin Pharmaceuticals, Ltd. stock logo
QNRX
Quoin Pharmaceuticals
-$0.11-$6.50-$6.39-$6.50N/AN/A
3/13/2025Q3 2025
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
-$2.53-$2.5722-$0.0422-$2.57N/AN/A
3/13/2025Q4 2024
Quoin Pharmaceuticals, Ltd. stock logo
QNRX
Quoin Pharmaceuticals
-$17.50-$12.25+$5.25-$0.35N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/AN/A
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
N/AN/AN/AN/AN/A
Quoin Pharmaceuticals, Ltd. stock logo
QNRX
Quoin Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Dynatronics Co. stock logo
DYNT
Dynatronics
0.25
1.21
0.60
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/A
0.14
0.14
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
0.01
1.72
1.52
Quoin Pharmaceuticals, Ltd. stock logo
QNRX
Quoin Pharmaceuticals
N/A
3.02
3.02

Institutional Ownership

CompanyInstitutional Ownership
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
10.92%
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
17.24%
Quoin Pharmaceuticals, Ltd. stock logo
QNRX
Quoin Pharmaceuticals
8.63%

Insider Ownership

CompanyInsider Ownership
Dynatronics Co. stock logo
DYNT
Dynatronics
7.98%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
46.50%
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
1.80%
Quoin Pharmaceuticals, Ltd. stock logo
QNRX
Quoin Pharmaceuticals
3.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Dynatronics Co. stock logo
DYNT
Dynatronics
20010.62 million8.11 millionNot Optionable
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
525.59 million5.57 millionNot Optionable
Heart Test Laboratories, Inc. stock logo
HSCS
Heart Test Laboratories
101.08 million962,000Not Optionable
Quoin Pharmaceuticals, Ltd. stock logo
QNRX
Quoin Pharmaceuticals
4588,0004.86 millionNot Optionable

Recent News About These Companies

A Peek at Quoin Pharmaceuticals's Future Earnings
Quoin Pharmaceuticals Ltd – ADR trading halted, news pending
Quoin Pharmaceuticals reports Q4 EPS (35c) vs ($2.08) last year

New MarketBeat Followers Over Time

Media Sentiment Over Time

Dynatronics stock logo

Dynatronics NASDAQ:DYNT

$0.08 -0.02 (-18.60%)
As of 05/14/2025 02:52 PM Eastern

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

GlucoTrack stock logo

GlucoTrack NASDAQ:GCTK

$0.15 +0.00 (+2.47%)
As of 05/14/2025 04:00 PM Eastern

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Heart Test Laboratories stock logo

Heart Test Laboratories NASDAQ:HSCS

$3.34 +0.01 (+0.30%)
As of 05/14/2025 04:00 PM Eastern

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Quoin Pharmaceuticals stock logo

Quoin Pharmaceuticals NASDAQ:QNRX

$7.65 +1.29 (+20.28%)
As of 05/14/2025 04:00 PM Eastern

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia.